J&J Unit Takes On Wyeth's Effexor In Patent Suit

Law360, New York (July 27, 2006, 12:00 AM EDT) -- A pharmaceutical unit of health care giant Johnson & Johnson has filed a patent infringement lawsuit against U.S. rival Wyeth over the drug-delivery system used in Wyeth’s popular antidepressant Effexor XR.

The suit was filed on behalf of J&J’s Mountainview, Calif.-based subsidiary Alza Corp., which specializes in drug-delivery systems. The lawsuit was filed July 26 in the U.S. District Court for the Eastern District of Texas.

In the complaint, Alza accused Wyeth of willfully infringing its patent covering controlled-release dosage technology for Effexor’s specific chemical compound....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.